Who invested in Apellis Pharmaceuticals?
Apellis Pharmaceuticals's investors include Aju IB Investment and Morningside Private Investors.
United States · Series C startup
5 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$62Mraised across 5 rounds since 2010, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $6.0M sold, first sale Dec 2014
No investor was named in the report.
From a historical funding recordSEC filing: $18M sold, first sale Jul 2013
No investor was named in the report.
Reported by venturedeal.comSEC filing: $6.0M sold, first sale Jul 2013
No investor was named in the report.
Reported by sec.govSEC filing: $3.0M sold, first sale May 2011
No investor was named in the report.
Reported by sec.govSEC filing: $1.7M sold, first sale May 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Apellis Pharmaceuticals's investors include Aju IB Investment and Morningside Private Investors.
Apellis Pharmaceuticals has raised $62M across 5 rounds since 2010.
Apellis Pharmaceuticals's most recent round was a Series C of $33M in Dec 2014.
Its most recent round, $33M in Dec 2014, is also its largest on record.
Apellis Pharmaceuticals's first round on record, in Dec 2014, was backed by Aju IB Investment and Morningside Private Investors.
Apellis Pharmaceuticals's latest named round is a Series C, in Dec 2014.
Apellis Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.